BRIEF — Promethera estalishes Tokyo branch

Belgian bioscience firm Promethera has announced the foundation of a new Tokyo office, Promethera Biosciences Japan Branch.

The move marks the beginning of Promethera's efforts to expand into the lucrative Asian market.

Promethera's president and chief executive, John Tchelingerian, said: "Adding a local presence in Japan, in addition to our corporate headquarters and growing product development organization in Belgium, our US operations and manufacturing center of excellence in the North Carolina Research Triangle, as well as our newly announced Swiss subsidiary Baliopharm AG, represents a key milestone for Promethera in continuing to establish an international footprint."